Cancer immunotherapy: harnessing the immune system to battle cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26325031.
- Also identified by DOI 10.1172/JCI83871 and PMC identifier 4588312.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The recent clinical successes of immune checkpoint blockade and chimeric antigen receptor T cell therapies represent a turning point in cancer immunotherapy. These successes also underscore the importance of understanding basic tumor immunology for successful clinical translation in treating patients with cancer. The Reviews in this Review Series focus on current developments in cancer immunotherapy, highlight recent advances in our understanding of basic aspects of tumor immunology, and suggest how these insights can lead to the development of new immunotherapeutic strategies.
Medical subject headings
- Immunotherapy
- Neoplasms